Suspension aerosol formulations of pharmaceutical products

Details Suspension aerosol formulations of pharmaceutical products Suspension aerosol formulations of pharmaceutical products

2007-01-09

2007-01-09

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C424S046000, C424S489000

Reexamination Certificate

active

10934611

ABSTRACT:
Pharmaceutical preparations for producing powder aerosols using propellant gases which use TG 227, and possibly also TG 11, TG 12, TGH 114, propane, butane, pentane or DME.

REFERENCES:
patent: 2490764 (1949-12-01), Benning et al.
patent: 3014844 (1961-12-01), Thiel et al.
patent: 3095355 (1963-06-01), Abramson
patent: 3219533 (1965-11-01), Mullins
patent: 4044126 (1977-08-01), Cook et al.
patent: 4174295 (1979-11-01), Bargigia et al.
patent: 4352789 (1982-10-01), Thiel
patent: 4810488 (1989-03-01), Jinks
patent: 4814161 (1989-03-01), Jinks et al.
patent: 5118494 (1992-06-01), Schultz et al.
patent: 5182097 (1993-01-01), Byron et al.
patent: 5605674 (1997-02-01), Purewal et al.
patent: 5653962 (1997-08-01), Akehurst et al.
patent: 5674471 (1997-10-01), Akehurst et al.
patent: 5695743 (1997-12-01), Purewal et al.
patent: 5891420 (1999-04-01), Cutie
patent: 6149892 (2000-11-01), Britto
patent: 6153173 (2000-11-01), Sapsford et al.
patent: 2075058 (1991-08-01), None
patent: 1542076 (1970-03-01), None
patent: 1719443 (1972-04-01), None
patent: 27 03 119 (1977-08-01), None
patent: 3903336 (1990-08-01), None
patent: 40 03 270 (1991-08-01), None
patent: 315783 (1987-05-01), None
patent: 0 247 608 (1987-12-01), None
patent: 0 384 371 (1990-08-01), None
patent: 0 504 112 (1992-09-01), None
patent: 0 550 031 (1993-07-01), None
patent: 0653205 (1995-05-01), None
patent: 0656 206 (1995-06-01), None
patent: 837465 (1958-01-01), None
patent: 902590 (1962-08-01), None
patent: 2 001 334 (1979-01-01), None
patent: 2046093 (1980-11-01), None
patent: 2 125 426 (1984-03-01), None
patent: 55131096 (1980-11-01), None
patent: 022 72084 (1989-04-01), None
patent: WO 86/03750 (1986-07-01), None
patent: WO 86/04233 (1986-07-01), None
patent: WO 91/11173 (1991-08-01), None
patent: WO 91/11496 (1991-08-01), None
patent: WO 92/22288 (1992-12-01), None
patent: WO 96/19198 (1996-06-01), None
patent: WO 98/34595 (1998-08-01), None
Du Pont: Fluorocarbon/Ozone: Alternatives to Fully Halogenated Chlorofluorocarbons: The Du Pont Development Program; Mar. 1987.
Research Disclosure, May 1989, Kenneth Mason Publications Ltd., ISSN 0374-4353.
F.X. Fischer et al. “CFC Propellant Substitution: International Perspectives,” Pharm. Technol.Inc., Sep. 1989, pp. 44, 46, 50, 52.
L. Lachman et al., “The Theory of Practice of Industrial Pharmacy,” Philadelphia, Ch. 20, p. 590 and 603-604, 1986.
Hoeschst Press Release #7252, “Hoechst: Development of Alternatives to Fully Halogenated CFC's Takes Priority” Oct. 25, 1989.
J.Wesley Clayton, Jr., Ph.D. Fluorocarbon Toxicity: Past, Present, Future; J. Soc. Cosmetic Chemists, vol. 18, pp. 333-350, May 27, 1967.
The Condensed Chemical Dictionary, 5th printing, 1965, State College, PA. p. 26.
O-A Neumueller, Rompps Chemie-Lexikon, 8, Aufl, 1987, vol. 5, pp. 3931.
A. Oberholz, Frankfurter Allgemeine Zeitung, Oct. 25, 1989, p. 7, “Fur den Schutz des Lebens auf der Erde;” EnglishTranslation “For Preservation of Life on Earth.”
Respiratory Drug Delivery, editor, Peter R. Byron, based on a symposium held May 1988 at the Univ. of Kentucky, P. R. Byron editor, RM161.R448, 1990 CRC Press, Inc., Library of Congress #89-2401; pp. 40-43 and 250.
Proceedings of the Workshop on High Temperature Heat Pumps, Hannover, Nov. 1989; pp. 60-66.
P.A. Sanders, Handbook of Aerosol Technology, 2nd Edition, 1979, Chapter 21, pp. 400-411.
Helskel (Hoeschst), Hepafluorpropan in pharmazeutischen Aerosolen, notiz ueber elnen besuch bel der firma Boehringer Ingelheim KG Apr. 29, 1987.
Noelken (Hoechst), Toxikologische Entwicklung von FKW 227 Gespraechsnotiz (memo) Boehringer Ingelhelm KG.
DIN Safety Data Sheet, Hoechst AG, Jan. 25, 1988.
Blick auf Hoechst: HP 029, Nr. 8, Dec. 1989.
Hoechst zum Ersatz von FCKW, Stand: Sep. 1990.
Karl Thoma, Aerosole: Moeglichkeiten und Probleme einer Darreichungsform, Werbe und Vertriebsgesellschaft Deutscher Apotheker m.b.H., Frankfurt am Main, 1979 pp. 153-161.
F. Moren et al.; Aerosols in Medicine Principles, Diagnosis and Theraphy, Elsevier, 1985, pp. 261-278.
Respiratory Drug Delivery, editor, Peter R. Byron, based on a symposium held May 1988 at the Univ. of Kentucky, P. R. Byron editor, RM161.R448, 1990 CRC Press, Inc., Library of Congress #89-24018; pp. 168-186.
F. Moren, AB Draco, “Dosage Forms and Formulations for Drug Administration to the Respiratory Tract” Drug Development and Industrial Pharmacy, 1987, 13 p. 704.
Chemical Business New Bulletin, vol. 19, Dec. 1, 1989.
Remington's Pharmaceutical Sciences, 13th Edition, Mack Publishing, Easton, PA, 1965 Chapter 42, pp. 661-662.
A.T. Florence & D. Attwood, Physicochemical Principles of Pharmacy, 1981, Macmillian Press.
IMS Health—Midas Feb. 25, 2000, “Aerosol Usage in Germany” pp. 1 and 2.
The Merck Index, 11th Edition, 1989.
The Science and Technology of Aerosol Packaging, Sciarra and Stoller, John Wiley & Sons, 1974; pp. 435-450.
T. S. Johnson and H. Deger of Hoechst Celanese Corp., “Specialty fluoroaliphatic chemicals,” a paper presented at Chemspec USA 1989, pp. 61-63, a symposium highlighting innovation, manufacture and applications of specialty chemicals held Oct. 10-11, 1989.
Transcript of Faxes: The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit, London Sep. 13, 1995, CPMP/503/95.
Abstract to Hoechst Marion Roussel Pharmaceuticals, Respiratory Drug Delivery V, Program Proc., 5th (1996).
Auszug aus der Beilstein-Datenbank (Abstract of the Beilstein-Databank).
Hoechst High Chem Magazin 16/1994, p. 42.
J.J. Sciarra & A.J. Cutie: The Theory and Practice of Industrial Pharmacy; Pharmaceutical Aerosols-chapter 20, pp. 589-618; Supplied by the British Library.
Auszug Rote Liste, 1989, Praeparate der Firma Hoechst.
Priority Document for WO 91/11173 and PCT/GB 91/00133 dated Feb. 2, 1990.
Physician's Desk Reference Germany (Rote Liste/Fachinformation) Ailergospasmin N, VIATRIS Gmbh & Co. KG Intal, Aarane N (Aventis Pharma).
Physician's Desk Reference Germany (Rote Liste/Fachinformation) Apaflurane (Copyright 2004 American Chemical Society.
WHO Drug Information Vo. 16, No. 4, 2002.
Solkane(R) 227 pharma and 134a Pharma (NEW)—Datasheet.
Remington's 17th Edition, Pharmaceutical Sciences, 1985.
Physician's Desk Reference, 43rd Edition 1989.
List of Some Suspension Products for Oral Inhalation.

Affiliated with

Also associated with

Rating

Suspension aerosol formulations of pharmaceutical products does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suspension aerosol formulations of pharmaceutical products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suspension aerosol formulations of pharmaceutical products will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3759759